{
  "id": 2192882,
  "title": "Three deaths in China shake trust in its speedy clinical trial system",
  "url": "https://urgent.news/2026/08/20/three-deaths-in-china-shake-trust-in-its-speedy-clinical-trial-system",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-20T18:05:41.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/three-deaths-in-china-shake-trust-in-its-speedy-clinical-trial-system/"
  },
  "original_language": "en",
  "account": null,
  "summary": "China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials. The studies, also known as IITs, allow experimental cell and ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Bristol Myers' partner Biokin says bispecific ADC clears fourth cancer trial in China",
        "url": "https://urgent.news/2026/08/19/bristol-myers-partner-biokin-says-bispecific-adc-clears-fourth-cancer",
        "published": "2026-08-19T11:05:05.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}